Possibility of hyperpyrexia with antipsychotic and anticholinergic drugs
Lee, B.S.
Journal of Clinical Psychiatry 47(11): 571
1986
ISSN/ISBN: 0160-6689 PMID: 3771507 Document Number: 283547
Document emailed within 1 workday
Related Documents
Alexandropoulou, P.; Mauri, D.; Rigatou, E.; Karampoiki, V. 2000: Hyperpyrexia secondary to acute hypocalcemic status. Is there a role for calcitonin therapy in bone metabolism derangements due to anticonvulsant drugs? Minerva Medica 91(11-12): 321-323Hughes, D.T. 1987: The use of anticholinergic drugs in nocturnal asthma Postgraduate Medical Journal 63(Suppl 1): 47-51
Bourin, M. 2006: Pharmacology of antipsychotic drugs L'Encephale 32 Pt 2: S8-S9
Raskind, M.A.; Risse, S.C. 1986: Antipsychotic drugs and the elderly Journal of Clinical Psychiatry 47 Suppl: 17-22
Vieta, E. 2004: Antipsychotic drugs and pregnancy Medicina clinica 123(13): 517-8; author reply 518
Vanden Bussche, G.; Gelders, Y.G.; Heylen, S.L. 1990: Development of new antipsychotic drugs Acta Psiquiatrica y Psicologica de America Latina 36(1-2): 13-25
1974: Effects of systemic drugs with anticholinergic properties on glaucoma Medical Letter on Drugs and Therapeutics 16(6): 28
Machácek, V.; Zýka, J. 1976: Analytical studies on new anticholinergic drugs. I. Identification reactions Ceskoslovenska Farmacie 25(3-4): 102-104
2000: COPD therapy. More frequent administration of anticholinergic drugs MMWFortschrittederMedizin 142(33-34): 61
Penny, J.L.; Bonanno, C.; Grace, W.J. 1962: Clinical studies on anticholinergic drugs using intragastric pH meter Current Therapeutic Research 4: 258-262
Wengert, J.W.; Ahmed, I. 1979: Antipsychotic drugs: problems and guidelines Nebraska Medical Journal 64(5): 139-140
Del Vecchio-Blanco, C.; Stroffolini, T. 1981: Anticholinergic and benzodiazepine drugs in the therapy of functional colonic diseases Minerva Dietologica e Gastroenterologica 27(4): 593-598
Meco, G.; Casacchia, M.; Lazzari, R.; Franzese, A.; Castellana, F.; Carta, A.; Iannuccelli, M.; Agnoli, A. 1984: Mental impairment in Parkinson's disease. the role of anticholinergic drugs Acta Psychiatrica Belgica 84(4): 325-335
Schwabl, U.; Schwabl, H.; Ulmer, W.T. 1990: Reproducibility of the bronchospasmolytic effect of anticholinergic drugs and beta-sympathomimetics Pneumologie 44(Suppl 1): 358-359
Rimón, R.; Leinonen, E. 2002: Should the second generation antipsychotic agents be used as drugs of choice? Duodecim; Laaketieteellinen Aikakauskirja 118(6): 585-590
Deuschle, M. 2005: Diabetes in treatment with antipsychotic drugs: who is at risk] MMW Fortschritte der Medizin 147(51-52): 34
Dumortier, G.; Cabaret, W.; Stamatiadis, L.; Saba, G.; Benadhira, R.; Rocamora, J.-F.; Aubriot-Delmas, B.; Glikman, J.; Januel, D. 2002: Hepatic tolerance of atypical antipsychotic drugs L'Encephale 28(6 Part 1): 542-551
Greene, P.; Shale, H.; Fahn, S. 1988: Experience with high dosages of anticholinergic and other drugs in the treatment of torsion dystonia Advances in Neurology 50: 547-556
Georget, S.; Giesenfeld, A.; Gonzalvez, M.F.; Mangin, A.; Montaut, T.; Pareja, J.P.; Kahn, J.P. 1998: Survey of the quality of prescribing anticholinergic drugs in neuroleptic treated patients L'Encephale 24(2): 100-107
Firestone, A. 2005: Weight gain and diabetes with "second-generation" antipsychotic drugs Medical Journal of Australia 182(12): 652-653